As patentes de segundo uso podem ser uma política construtiva no tratamento das doenças negligenciadas? Um estudo de caso concreto das novas aplicações dos compostos amphotericin, dapsone e eflornitine.

Abstract

What should be the role of the state in facing neglected diseases? What should be the degree of intervention in this area? How far must it act to ensure a good life to each citizen, according to Ronald Dworkin (2011)? What is the relationship between second and neglected diseases? Why integrity in law? Supported by the idea that questions are more important than answers, this graduation thesis intends to analyze the problem of neglected diseases, and explain a constructive policy able to stop its logic of exclusion to health access. The discussion focuses on a necessary constructive re-interpretation of policy, taking into account the theoretical reference of integrity in law, based on Dworkin’s theory (2007). To achieve this purpose and due to the scarcity of material available in this area, this review must examine the patents for second use and its relationship to drugs for neglected diseases with an interdisciplinary research, using an interview with an expert in this area, and also, case studies. Finally, we intend to demonstrate that the action of the state is necessary in this range, to guarantee the right to health of those affected by neglected diseases and consequently, a good life, so that the second use, if used, will be only an accessory way .